Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DLU2 | ISIN: SE0009414576 | Ticker-Symbol: OND
Frankfurt
31.03.25
08:19 Uhr
0,131 Euro
-0,001
-1,06 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ONCOPEPTIDES AB Chart 1 Jahr
5-Tage-Chart
ONCOPEPTIDES AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,1320,13721:57

Aktuelle News zur ONCOPEPTIDES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.02.Oncopeptides AB: Oncopeptides publishes year-end report 2024276Stockholm - February 27, 2025 - Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today publishes the year-end report for 2024. "Pepaxti sales increased about 35 percent...
► Artikel lesen
27.01.Italian decision sets up launch of Oncopeptides' Pepaxti7
07.11.24Oncopeptides AB: Oncopeptides publishes Q3 report 2024204Stockholm - November 7, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the third quarter 2024. "In the...
► Artikel lesen
14.08.24Oncopeptides AB: Oncopeptides publishes Q2 report 2024366Stockholm - August 14, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the second quarter 2024. "During...
► Artikel lesen
30.05.24Oncopeptides AB: Oncopeptides publishes Q1 report 2024223Stockholm - May 30, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the first quarter 2024. "Seasonal...
► Artikel lesen
18.04.24Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Oncopeptides AB (Record id 259984)471With effect from April 19, 2024, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including April 29, 2024. Instrument: Subscription...
► Artikel lesen
15.04.24Oncopeptides AB: Oncopeptides secures national reimbursement for Pepaxti in Spain361- Preparations ongoing with full launch expected to commence after summer. Stockholm, April 15, 2024 - Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, today announces...
► Artikel lesen
15.04.24XFRA CAPITAL ADJUSTMENT INFORMATION - 15.04.2024362Das Instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY wird ex Kapitalmassnahme gehandelt am 15.04.2024 The instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY is traded ex capital...
► Artikel lesen
ONCOPEPTIDES Aktie jetzt für 0€ handeln
08.04.24Oncopeptides AB: Oncopeptides announces final terms for the fully guaranteed rights issue374THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR...
► Artikel lesen
04.04.24Oncopeptides AB: Oncopeptides releases first quarter 2024 sales187Stockholm - April 4, 2024 - Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the unaudited net sales for the first quarter of 2024. Oncopeptides...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,5